Outcomes Following Resection of Stage I to III Thymic Tumors in High-Volume Centers

Sara Sakowitz; Syed Shahyan Bakhtiyar; Saad Mallick; Jane Yanagawa; Peyman Benharash

doi:10.1001/jamasurg.2024.4093

Outcomes Following Resection of Stage I to III Thymic Tumors in High-Volume Centers

JAMA Surg. 2025 Jan 1;160(1):105-108. doi: 10.1001/jamasurg.2024.4093.

Authors

Sara Sakowitz¹, Syed Shahyan Bakhtiyar¹, Saad Mallick¹, Jane Yanagawa², Peyman Benharash^{1

3}

Affiliations

¹ Cardiovascular Outcomes Research Laboratories, Department of Surgery, University of California, Los Angeles.
² Division of Thoracic Surgery, Department of Surgery, University of California, Los Angeles.
³ Center for Advanced Surgical and Interventional Technology, University of California, Los Angeles.

PMID: 39412764
PMCID: PMC11581711 (available on 2025-10-16)
DOI: 10.1001/jamasurg.2024.4093

No abstract available

Plain language summary

This cohort study examines the association of patient outcomes following resection of stage I to III thymic tumors with whether the procedure was conducted at high-volume centers.